-
1 month ago | 
sudouest.fr | Suzanne Nielsen |Nicole Lee
Des retours ponctuels de certains professionnels ont suscité des inquiétudes quant à l’utilisation par des jeunes de benzodiazépines délivrées sur ordonnance, comme le Xanax, à des fins récréatives. En Australie, les détections de ces substances par la police des frontières ont presque doublé au cours des cinq dernières années. À lire aussi : Soumission chimique par benzodiazépines, anxiolytiques ou sédatifs : quels effets ? quelle prise en charge des victimes ? quelle prévention ?
-
1 month ago | 
theconversation.com | Nicole Lee |Suzanne Nielsen
Perte de mémoire, dépendance, voire même une dépression respiratoire pouvant entraîner la mort dans des cas extrêmes… les risques liés aux usages détournés de médicaments de la famille des benzodiazépines, notamment chez les jeunes, sont sérieux. Des retours ponctuels de certains professionnels ont suscité des inquiétudes quant à l’utilisation par des jeunes de benzodiazépines délivrées sur ordonnance, comme le Xanax, à des fins récréatives.
-
1 month ago | 
theconversation.com | Nicole Lee |Suzanne Nielsen
Perte de mémoire, dépendance, voire même une dépression respiratoire pouvant entraîner la mort dans des cas extrêmes… les risques liés aux usages détournés de médicaments de la famille des benzodiazépines, notamment chez les jeunes, sont sérieux. Des retours ponctuels de certains professionnels ont suscité des inquiétudes quant à l’utilisation par des jeunes de benzodiazépines délivrées sur ordonnance, comme le Xanax, à des fins récréatives.
-
Jan 21, 2025 | 
theconversation.com | Nicole Lee |Suzanne Nielsen
Anecdotal reports from some professionals have prompted concerns about young people using prescription benzodiazepines such as Xanax for recreational use. Border force detections of these drugs have almost doubled in the past five years, further fuelling the worry. So why do young people use them, and how do the harms differ to those used as prescribed by a doctor? What are benzodiazepines? You might know this large group of drugs by their trade names.
-
Aug 29, 2024 | 
ajp.com.au | Megan Haggan |Leopold Hamulczyk |Suzanne Nielsen |JOhn Smith |John Smith
The IV fluid situation is “stabilising,” says health minister Mark Butler, but one expert says Labor’s approach does not fix the underlying issue On Wednesday (28 August), Butler said that the Albanese Government has worked with local producers and suppliers to secure supply of more than 22 million additional IV fluid bags for the affectedThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
-
Aug 29, 2024 | 
ajp.com.au | Megan Haggan |Leopold Hamulczyk |Suzanne Nielsen |JOhn Smith |John Smith
Barbiturate poisonings on the rise, a proposal to require scripts for the “so-called tranquilising drugs” and a crackdown on arsenic sales – how pharmacy was changing in the 50s The August 1956 edition of the Australasian Journal of Pharmacy looked at a number of drugs of concern, starting with the barbiturates class. We took aThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
-
Aug 29, 2024 | 
ajp.com.au | Nicholas O’Donoghue |Suzanne Nielsen |JOhn Smith |John Smith |Sheshtyn Paola
Stakeholders believe the government should have given pharmaceutical companies an 18 to 24-month window to comply with minimum stock requirements Data from the Review of the Minimum Stockholding Requirements - Early review of the 12-month progress and outcomes report found that less than half (45%) of designated brands were compliance with the requirements throughout the firstThis content is restricted to registered users only.
-
Aug 29, 2024 | 
ajp.com.au | Kate Cowling |Suzanne Nielsen |JOhn Smith |John Smith |Nicholas O’Donoghue
Pharmacy business delivers growth for Wesfarmers, with Priceline franchise network continuing its expansion Wesfarmers Health lifted its revenue by almost 6% in the most recent financial year, with strong Priceline sales helping to drive the division’s growth. The health arm of the diversified company increased its revenue to $5,625m and earnings to $50m, it toldThis content is restricted to registered users only.
-
Aug 29, 2024 | 
ajp.com.au | Nicholas O’Donoghue |Suzanne Nielsen |JOhn Smith |John Smith |Sheshtyn Paola
Medication management software provider, MedAdvisor’s ‘pathway to profitability’ is delivering with the firm announcing its first net profit after tax Realigned pharmacy fees and the expansion of pharmacists’ scope of practice are fuelling revenue growth for MedAdvisor. The company today (29 August 2024), reported its inaugural positive EBITDA (earnings before interest taxes depreciation andThis content is restricted to registered users only.
-
Jul 7, 2024 | 
eastmojo.com | Suzanne Nielsen |Louisa Picco
Representational Image This drug to prevent opioid deaths is free, and available without a prescription across Australia. So why has uptake of naloxone been slow? Australia is in the grips of an opioid crisis. Opioid related-deaths — some from illicit drugs including heroin, but many more from prescription opioids commonly used to treat pain — have dramatically increased over the past two decades.
